Creative Medical Technology Holdings Inc (CELZ)

[uvaphd]

Fair points in theory. Are you also willing to consider that (and I’m eager to read your thoughts):

1. In addition to awaiting results, docs may also be reluctant because they think they can inject the stem cells on their own, using some means other than CELZ’ kit?
2. In this event, the already cash-strapped company would need to pay to pursue patent enforcement?
3. Several other companies with MUCH higher PPS are legitimately valued, as are we (I don’t tend to believe this, but at some point one has to wonder)